Cargando…

Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis()()

PURPOSE: The prognostic value of SMAD4 in pancreatic cancer has been evaluated in several studies. However, the conclusions remain controversial. Therefore, we aimed to evaluate the association between SMAD4 expression and the outcome of pancreatic cancer patients by performing a meta-analysis. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shugang, Xing, Hongfa, Yang, Jianpeng, Liu, Xu, Zheng, Jingqi, Feng, Xiangxiang, Li, Wei, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800056/ https://www.ncbi.nlm.nih.gov/pubmed/26947875 http://dx.doi.org/10.1016/j.tranon.2015.11.007

Ejemplares similares

Meta-Analysis of the Prognostic Value of Smad4 Immunohistochemistry in Various Cancers
por: Du, Yiping, et al.
Publicado: (2014)

Prognostic value of functional SMAD4 localization in extrahepatic bile duct cancer
por: Takayama, Hirotoshi, et al.
Publicado: (2022)

Knockdown of Collagen Triple Helix Repeat Containing 1 (CTHRC1) Inhibits Epithelial–Mesenchymal Transition and Cellular Migration in Glioblastoma Cells
por: Liu, Jianpeng, et al.
Publicado: (2017)

Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis
por: Hu, Geng-yuan, et al.
Publicado: (2016)

Expression profile and prognostic value of NNMT in patients with pancreatic cancer
por: Xu, Yong, et al.
Publicado: (2016)

Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
por: Wang, Jin-Dao, et al.
Publicado: (2016)

A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
por: Voorneveld, Philip W., et al.
Publicado: (2015)

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer
por: Jia, Xu, et al.
Publicado: (2017)

Prognostic value of the creatinine-albumin ratio in acute pancreatitis debridement
por: Zhao, Zhifeng, et al.
Publicado: (2020)

Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma
por: Li, Guang-Jun, et al.
Publicado: (2016)

Prognostic value of microRNAs in pancreatic cancer: a meta-analysis
por: Zhao, Fei, et al.
Publicado: (2020)

Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis
por: Yang, Li, et al.
Publicado: (2023)

The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis
por: Chen, Xin, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
por: Li, Zhiqiang, et al.
Publicado: (2023)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

Prognostic values of HE4 expression in patients with cancer: a meta-analysis
por: Dai, Cong, et al.
Publicado: (2018)

A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
por: LI, MINGYUE, et al.
Publicado: (2016)

Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis
por: Wang, Chengcheng, et al.
Publicado: (2022)

SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
por: Dai, Chao, et al.
Publicado: (2021)

A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
por: Singh, Puneet, et al.
Publicado: (2011)

Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer
por: Bian, Xiaojie, et al.
Publicado: (2018)

Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis
por: Fang, Zengli, et al.
Publicado: (2020)

SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
por: Dardare, Julie, et al.
Publicado: (2020)

Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value
por: Qiu, Miaozhen, et al.
Publicado: (2016)

Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Han, Wei, et al.
Publicado: (2016)

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
por: Ahmed, Sunjida, et al.
Publicado: (2017)

RhoT1 and Smad4 Are Correlated with Lymph Node Metastasis and Overall Survival in Pancreatic Cancer
por: Jiang, Hua, et al.
Publicado: (2012)

Smad4 Deficiency Promotes Pancreatic Cancer Immunogenicity by Activating the Cancer‐Autonomous DNA‐Sensing Signaling Axis
por: Xiong, Wenjing, et al.
Publicado: (2022)

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
por: Meng, Qingcai, et al.
Publicado: (2017)

Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis
por: Yu, Min, et al.
Publicado: (2019)

Inhibitory Smads suppress pancreatic stellate cell activation through negative feedback in chronic pancreatitis
por: Lin, Hao, et al.
Publicado: (2021)

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019)

Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses
por: Li, Tian-Hao, et al.
Publicado: (2023)

The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
por: Liu, Cheng-Fei, et al.
Publicado: (2014)

HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer
por: Fang, Yuan, et al.
Publicado: (2020)

Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer
por: Hurwitz, Eric, et al.
Publicado: (2023)

Association of SMAD4 loss with drug resistance in clinical cancer patients: A systematic meta-analysis
por: Xu, Wei, et al.
Publicado: (2021)

Roles of Smads Family and Alternative Splicing Variants of Smad4 in Different Cancers
por: Ullah, Irfan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i5qjrukh1619avh7fj6fk5r4m8